Bibliographic Details
| Title: |
Clinical Benefit within Patient Subgroups Receiving c7E3 Fab (Abciximab) During Percutaneous Coronary Revascularization: Subgroup Analysis from the EPIC Trial. |
| Authors: |
Aguirre FV; J.G. Mudd Cardiac Catheterization Laboratory, St. Louis University Health Sciences Center, 3635 Vista Avenue at Grand, St. Louis, MO, 63110, USA., Topol EJ, Anderson KM, Kleiman NS, Weisman HF, FitzPatrick SE, Califf RM |
| Source: |
The Journal of invasive cardiology [J Invasive Cardiol] 1996; Vol. 8 Suppl B, pp. 21B-29B. |
| Publication Type: |
Journal Article |
| Journal Info: |
Publisher: HMP Communications Country of Publication: United States NLM ID: 8917477 Publication Model: Print Cited Medium: Internet ISSN: 1557-2501 (Electronic) Linking ISSN: 10423931 NLM ISO Abbreviation: J Invasive Cardiol |
| Database: |
MEDLINE Ultimate |
